Enveric Biosciences (ENVB) Q1 2025 Earnings
ENVB·Reported May 14, 2025·Before market open
Diluted EPS came in at $-1.22 (+86.7% YoY), beat the $-6.00 consensus by $4.78.
Diluted EPS
$-1.22beat by $4.78
Consensus: $-6.00
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Enveric Biosciences's Q1 2025 earnings report.
Enveric Biosciences (ENVB) reported Q1 2025 earnings on May 14, 2025 before market open.
Enveric Biosciences reported diluted EPS of $-1.22 for Q1 2025.
EPS beat the consensus estimate of $-6.00 by $4.78.
Compared to the same quarter a year prior, diluted EPS grew 86.7% from $-9.15.
You can read the 10-Q periodic report (0001641172-25-010345) directly on SEC EDGAR. The filing index links above go to sec.gov.